Evidence map›Paper›PMID 42517115›Full record

ReviewFrontiers in public health2026

Artificial intelligence, autism care, and health equity: a public health narrative review.

Xugao Han, Lingyan Weng, Houxi Xu

Abstract readReview
In one paragraph

Review in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xugao HanSchool of Medical Humanities, Nanjing University of Chinese Medicine, Nanjing, China.
Lingyan WengSchool of Tourism Management, Nanjing Institute of Tourism and Hospitality, Nanjing, China.
Houxi XuKey Laboratory of Acupuncture and Medicine Research of Ministry of Education, Nanjing University of Chinese Medicine, Nanjing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autism spectrum disorder (ASD) is a common, lifelong neurodevelopmental condition whose recorded prevalence, diagnostic delays, and uneven distribution of specialist services create a growing public health challenge. Conventional screening and diagnostic pathways depend heavily on scarce specialist expertise, contributing to long waiting times and unequal access across income settings, regions, sex, ethnicity, language, and social position. This narrative review synthesises current applications of artificial intelligence (AI) and machine learning in autism screening, diagnostic support, intervention, and longitudinal monitoring, and reframes the evidence through a public health and health equity lens. We argue that AI's most important contribution to autism care is unlikely to lie in marginal improvements in classification accuracy alone. Rather, its potential value lies in expanding access, supporting task-sharing, shortening diagnostic pathways, enabling population-oriented screening, and reaching under-recognised groups such as girls and women, adults, ethnic and linguistic minorities, and populations in low-resource settings. At the same time, AI may create an equity paradox: technologies intended to reduce disparities may reproduce or amplify them if they are trained on non-representative data, deployed across a digital divide, or governed without adequate attention to privacy, accountability, and community trust. Whether AI narrows or widens autism-related health inequalities will depend on choices about data diversity, low-resource design, co-design with autistic communities, equity-sensitive evaluation, clinical integration, and proportionate regulation.

Indexed as

Artificial IntelligenceAutism Spectrum DisorderAutistic DisorderHealth EquityPublic HealthHumansMachine Learningaccess to careartificial intelligenceautism spectrum disorderdigital healthhealth equitymachine learningpublic healthscreening

Identifiers

PMID42517115
PMCPMC13402400

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.